Thermo Fisher Q4 revenue $11.45B (+7% YoY), adjusted EPS $5.40; FY2023 guidance: rev $45.3B

THERMO FISHER SCIENTIFIC INC.

2022-FY EPS reported $17.63 revenue$44,915,000,000

Q4 revenue $11.45B (+7% YoY); GAAP EPS $4.01 (vs $4.17), adjusted EPS $5.40 (vs $6.54).
Full year revenue $44.92B (+15% YoY); GAAP EPS $17.63 (vs $19.46), adjusted EPS $23.24 (vs $25.13).
Core organic revenue growth 14% in Q4 and FY2022; COVID-19 testing revenue $0.37B Q4, $3.11B FY.
FY2023 guidance: revenue ~$45.3B, Core organic growth 7%, adjusted EPS $23.70.
Completed acquisition of The Binding Site for $2.7B shortly after year-end; PPD integration on track.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

THERMO FISHER SCIENTIFIC INC. reported Full Year 2023 results: revenue $45.3 billion, EPS $23.7. Guidance initiated.

Period: Full Year 2023
Revenue: $45.3 billion
EPS: $23.7
Guidance: initiated
Result: guidance update

Exact text from the filing

The company expects to achieve 2023 revenue of $45.3 billion and full year Core organic revenue growth of 7%. The company expects to achieve adjusted EPS of $23.7

View on SEC.gov

6 earnings releases filed in the last 30 days. Browse all earnings releases →

THERMO FISHER SCIENTIFIC INC. filing history →

Source: SEC EDGAR

accession 0000097745-23-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.